2021 Bipolar Disorder Market Report- Size, Demand, Cost Structures, Latest trends,

The research report of the Bipolar Disorder Market provides a comprehensive overview of the market, size, and share. In addition, Bipolar Disorder Market provides the closest approximations of the revenue of the market and sub-segments across the different regions. The Bipolar Disorder Market research report is estimated to reach the highest CAGR. The Bipolar Disorder Market research report helps stakeholders understand the market pulse of the Bipolar Disorder Market and the key market drivers, challenges, restraints, and opportunities.

Get FREE PDF Sample of the Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5071117

Bipolar disorder, also known as bipolar depression or manic depression, is a psychological disorder that presents with severe shifts in mood from one extreme to another. The mood swings occur in a cyclic or periodic pattern that includes feelings of emotional highs (mania or hypomania) and lows (depression). The disease is considered on a spectrum that includes bipolar I, bipolar II, and cyclothymic disorder, and which will be referred to as bipolar spectrum disorder in this report. The prevalence of bipolar spectrum disorder varies significantly depending on the study population, diagnostic criteria used, and duration of survey (Wittchen, Nelson and Lachner, 1998; Fajutrao et al., 2009; Merikangas et al., 2010, 2011; Homish et al., 2013). The lifetime total prevalence of the bipolar spectrum of diseases ranges around the world from 0.1% in Nigeria to more than 6% in the US (Kessler, Berglund, et al., 2005; Merikangas et al., 2011).

In the 8MM, 12-month total prevalent cases of bipolar spectrum disorder are expected to increase from 13,446,327 cases in 2020 to 14,209,094 cases in 2030, at an Annual Growth Rate (AGR) of 0.57%. In 2030, the US will have the highest number of 12-month total prevalent cases of bipolar spectrum disorder in the 8MM, with 8,595,638 cases, whereas Japan will have the fewest 12-month total prevalent cases of bipolar spectrum disorder with 215,902 cases. In the 8MM, lifetime total prevalent cases of bipolar spectrum disorder are expected to increase from 22,988,066 cases in 2020 to 24,229,373 cases in 2030, at an AGR of 0.54%. In 2030, the US will have the highest number of lifetime total prevalent cases of bipolar spectrum disorder in the 8MM, with 13,712,952 cases, whereas Japan will have the fewest 12-month total prevalent cases of bipolar spectrum disorder with 649,964 cases. GlobalData epidemiologists attribute the increase in 12-month total prevalent cases of bipolar spectrum disorder and lifetime total prevalent cases of bipolar spectrum disorder to population dynamics in each market.

Scope of this Report-
Bipolar Disorder Market Report provides an overview of the risk factors, comorbidities, and global and historical trends for bipolar spectrum disorder in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and Canada). The report provides a 10-year epidemiological forecast of the 12-month and lifetime total prevalent cases of bipolar spectrum disorder. In this analysis bipolar spectrum disorder is grouped into the following groups for the 12-month and lifetime total prevalent cases -
- Bipolar I disorder, bipolar II disorder, and cyclothymic disorder.
- The report provides a 10-year epidemiological forecast for both 12-month and lifetime total prevalent cases of bipolar I, bipolar II, and cyclothymic disorder. The 12-month total prevalent cases of bipolar I, bipolar II, and cyclothymic disorder are further segmented by sex and age (13-18 years, 19-29 years, 30-39 years, 40-49 years, 50-59 years, 60-69 years, 70-79 years, and 80 years and older) in these markets.
- The bipolar disorder epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to Buy this Report-
The Bipolar Disorder Epidemiology series will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global bipolar disorder market.
- Quantify patient populations in the global bipolar disorder market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups that present the best opportunities for bipolar disorder therapeutics in each of the markets covered.
- Understand magnitude of bipolar spectrum disorder by bipolar I disorder, bipolar II disorder, and cyclothymic disorder.

Get Discount on Purchase this Report @ https://www.reportsnreports.com/purchase.aspx?name=5071117

Table of Contents
1 Bipolar Disorder: Executive Summary
1.1 Catalyst
1.2 Related Reports
1.3 Upcoming Reports
2 Epidemiology
2.1 Disease Background
2.2 Risk Factors and Comorbidities
2.3 Global and Historical Trends
2.4 8MM Forecast Methodology
2.4.1 Sources
2.4.2 Forecast Assumptions and Methods
2.4.3 Forecast Assumptions and Methods: 12-Month and Lifetime Prevalent Cases of Bipolar Disorder
2.5 Epidemiological Forecast for Bipolar Disorder (2020-2030)
2.5.1 12-Month Total Prevalent Cases of Bipolar I Disorder
2.5.2 Age-Specific 12-Month Total Prevalent Cases of Bipolar I Disorder
2.5.3 Sex-Specific 12-Month Total Prevalent Cases of Bipolar I Disorder
2.5.4 Lifetime Total Prevalent Cases of Bipolar I Disorder
2.5.5 Age-Specific Lifetime Total Prevalent Cases of Bipolar I Disorder
2.5.6 Sex-Specific Lifetime Total Prevalent Cases of Bipolar I Disorder
2.5.7 12-Month Total Prevalent Cases of Bipolar II Disorder
2.5.8 Age-Specific 12-Month Total Prevalent Cases of Bipolar II Disorder
2.5.9 Sex-Specific 12-Month Total Prevalent Cases of Bipolar II Disorder
2.5.10 Lifetime Total Prevalent Cases of Bipolar II Disorder
2.5.11 Age-Specific Lifetime Total Prevalent Cases of Bipolar II Disorder
2.5.12 Sex-Specific Lifetime Total Prevalent Cases of Bipolar II Disorder
2.5.13 12-Month Total Prevalent Cases of Cyclothymic Disorder
2.5.14 Age-Specific 12-Month Total Prevalent Cases of Cyclothymic Disorder
2.5.15 Sex-Specific 12-Month Total Prevalent Cases of Cyclothymic Disorder
2.5.16 Lifetime Total Prevalent Cases of Cyclothymic Disorder
2.5.17 Age-Specific Lifetime Total Prevalent Cases of Cyclothymic Disorder
2.5.18 Sex-Specific Lifetime Total Prevalent Cases of Cyclothymic Disorder
2.6 Discussion
2.6.1 Epidemiological Forecast Insight
2.6.2 COVID-19 Impact
2.6.3 Limitations of the Analysis
2.6.4 Strengths of the Analysis
3 Appendix
3.1 Bibliography
3.2 About the Authors
3.2.1 Epidemiologist
3.2.2 Reviewers
3.2.3 Global Director of Therapy Analysis and Epidemiology
3.2.4 Global Head and EVP of Healthcare Operations and Strategy
Contact Us

+ 1 888 391 5441
sales@reportsandreports.com

ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

This release was published on openPR.